gila monster and glp-1 🦎 One of the world's most talked-about medicines owes a lot to… a venomous lizard. Researchers studying the saliva of the discovered a molecule similar to GLP-1. That discovery helped Tirzepatide vs Retatrutide: Dual CAS 2381089-83-2 Quantity:One Month Subscription

gila monster and glp-1 🦎 One of the world's most talked-about medicines owes a lot to… a venomous lizard. Researchers studying the saliva of the discovered a molecule similar to GLP-1. That discovery helped Tirzepatide vs Retatrutide: Dual CAS 2381089-83-2 Quantity:One Month Subscription

Tirzepatide vs Retatrutide: Dual vs Triple Agonist Research Comparison | Guides | PeptideHub

Phase 2 results at 48 weeks (Jastreboff et al., NEJM 2023): Phase 3 TRIUMPH-4 at 68 weeks (Lilly Press Release, Dec 2025): The 12 mg dose produced 28.7% body weight loss, an average of 71.2 lbs from a 248.5 lb baseline

CAS 2381089-83-2

Quantity:One Month Subscription

The science is intriguing but low bioavailability has led the company to pursue very high doses